ETTAC-2
ETTAC-2 is a LRG1 PROTAC degrader. ETTAC-2 promotes ubiquitination and degradation of LRG1 (DC50 of 8.38 µM) . ETTAC-2 inhibits the TGF-β-Smad3 signaling pathway and diminishes the secretion of fibrosis-associated proteins. ETTAC-2 attenuates the progression of renal fibrosis[1].
Product Specifications
UNSPSC
12352209
Target
PROTACs; TGF-beta/Smad
Related Pathways
PROTAC; Stem Cell/Wnt; TGF-beta/Smad
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Purity
98.22
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C83H123N23O26S
Molecular Weight
1891.07
References & Citations
[1]Fan L, et al. Targeted degradation of LRG1 to attenuate renal fibrosis. Asian J Pharm Sci. 2024 Aug;19 (4) :100941.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog